Acme United Corporation Recalls Dukal BZK Antiseptic Towelettes Due to CGMP Deviations
According to the U.S. Census Bureau's American Community Survey (ACS) 5-year estimates, the CDC PLACES population-level health analysis, and the CMS Hospital Compare quality data, Areazine publishes editorial articles drawing on more than 19,000 U.S. city profiles. See our methodology for full source attribution and refresh cadence.
Acme United Corporation has voluntarily recalled several lots of Dukal BZK Antiseptic Towelettes distributed nationwide due to Current Good Manufacturing Practice (CGMP) deviations.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on April 2, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken — "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to — FDA Recalls — determines the regulatory framework behind it, which shapes what remedies (refunds, replacements, recalls, evacuations) are available to affected individuals and who holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to read it as a data point about the issuing system: how quickly FDA detected the hazard, how precise the geographic or product-identifier scope is, and whether similar notices have clustered in the same category or region in the last 90 days. Cluster patterns frequently precede a broader regulatory action — a single localized FDA recall is isolated; three of them within a quarter often indicate a supply-chain, infrastructure, or seasonal driver that will keep producing notices until something structural changes.
For decision-making, Areazine pairs each alert with the original agency URL, the full agency name, and a timestamp so you can verify the notice against the primary source before acting on it. Tags on this item (recall, product-safety, fda, antiseptic) map to related alerts in the same area of risk — browsing them together gives a clearer picture than any single notice alone, because the shape of an ongoing issue only becomes visible across multiple sequential alerts.
What Happened
Acme United Corporation has initiated a voluntary recall of Dukal BZK Antiseptic Towelettes. The recall, classified as Class II by the FDA, was prompted by Current Good Manufacturing Practice (CGMP) deviations. The recall was officially initiated on January 20, 2026, following notification sent to distributors and customers via letter.
Which Products Are Affected
The recall affects Dukal BZK Antiseptic Towelettes (Benzalkonium Chloride 0.13%) packaged in cases of 1,000 packs. The product is identified by NDC 65517-0004-1 and was manufactured for Dukal, LLC.
The following lot numbers and expiration dates are included in this recall:
- Lot MN31621: Expiration October 2026
- Lots MN14522, MN15522: Expiration April 2027
- Lots MN28122, MN31522: Expiration September 2027
- Lots MN04223, MN06023: Expiration February 2028
- Lot MN17223: Expiration May 2028
- Lot MN25123: Expiration August 2028
- Lots MN33123, MN33523: Expiration November 2028
These products were distributed nationwide within the United States.
What You Should Do
Consumers, retailers, and healthcare providers should immediately check their inventory for the affected lot numbers listed above. If you possess any of the recalled towelettes, you should stop using them. Acme United Corporation initiated the notification process via letter; affected parties should follow the instructions provided in that communication for the return or disposal of the product. For further information, the recalling firm is located in Shelton, CT.
Why This Matters
This recall is significant because CGMP deviations indicate that the manufacturing process did not meet the required regulatory standards to ensure the product's quality, strength, and purity. A Class II classification suggests that use of the product may cause temporary or medically reversible adverse health consequences.
Source
Information provided by the FDA under recall number D-0360-2026.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Frequently Asked Questions
Common questions about this FDA recall.
What is this FDA recall about? ▾
Which agency issued this alert? ▾
How severe is this alert? ▾
What area is affected? ▾
Where can I find more FDA Recalls updates? ▾
Primary source data
EPA Outdoor Air Quality Data
Federal monitoring network — every measurement we report
AirNow (EPA / NOAA)
Real-time AQI for every monitored U.S. location
National Weather Service
Active watches, warnings, and advisories — NOAA
CDC Air Quality & Health
Health-impact reference behind every AQI category